SCHEMBL706912

SCHEMBL706912

Brc1ccc(-c2cccc(-c3ccc(Br)cc3)c2-c2ccc(Br)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
MAPK1 P28482 3/20 0.48
PLK4 O00444 1/20 0.43
AURKA O14965 1/20 0.43
JAK2 O60674 1/20 0.43
LCK P06239 1/20 0.43
CDK1 P06493 1/20 0.43
CSF1R P07333 1/20 0.43
LYN P07948 1/20 0.43
FGFR1 P11362 1/20 0.43
SRC P12931 1/20 0.43
PRKACA P17612 1/20 0.43
RPS6KB1 P23443 1/20 0.43
CDK2 P24941 1/20 0.43
MARK3 P27448 1/20 0.43
AKT1 P31749 1/20 0.43
AKT2 P31751 1/20 0.43
KDR P35968 1/20 0.43
BLK P51451 1/20 0.43
CSNK2A1 P68400 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27922948 0.91 ALDH1A1 (0.58) ALDH1A1MAPK1PLK4AURKAJAK2
SCHEMBL2678819 0.86 ALDH1A1 (0.41) ALDH1A1MAPK1PLK4AURKAJAK2
SCHEMBL15954483 0.84 PLK4 (0.45) ALDH1A1MAPK1PLK4AURKAJAK2
SCHEMBL13098704 0.81 ALDH1A1 (0.50) ALDH1A1MAPK1PLK4AURKAJAK2
SCHEMBL7522172 0.80 ALDH1A1 (0.63) ALDH1A1MAPK1PLK4AURKAJAK2
SCHEMBL19125933 0.80 ALDH1A1 (0.63) ALDH1A1MAPK1PLK4AURKAJAK2
SCHEMBL29168515 0.80 ALDH1A1 (0.64) ALDH1A1MAPK1CDK2CYP2A6PTPRC
SCHEMBL28056371 0.80 MAPK1 (0.45) ALDH1A1MAPK1PLK4AKT3PTPRC
SCHEMBL24972613 0.80 CYP2A6 (0.52) ALDH1A1MAPK1CYP2A6PTPRCSLC6A3
SCHEMBL28789264 0.80 ALDH1A1 (0.52) ALDH1A1MAPK1PLK4AURKAJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2423241-A1 Unit with porous organic polymers and use of same Blücher GmbH (DE) 2012-02-29 EP disclosed
US-7101632-B2 Multilayer; electrodes with active compound inbetween FUJI PHOTO FILM CO., LTD. (JP) 2006-09-05 US disclosed
US-20040137274-A1 Cyclocondensed polycyclic hydrocarbon compound and light-emitting device using the same FUJI PHOTO FILM CO., LTD. 2004-07-15 US disclosed
US-6696178-B2 AMINE COMPOUND FUJI PHOTO FILM CO., LTD. (JP) 2004-02-24 US disclosed
US-20010008711-A1 Cyclocondensed polycyclic hydrocarbon compound and light-emitting device using the same UDC IRELAND LIMITED (IE) 2001-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010008711-A1 Cyclocondensed polycyclic hydrocarbon compound and light-emitting device using the same AHR, CRY1, ARNT ALDH1A1 511/4885MAPK1 1504/4885PLK4 4168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.